Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination

Transfusion

Volumn 47, Issue 6, 2007, Pages 1062-1070

  Sawyer, Lynette ^a   Hanson, Deborah ^a   Castro, Grace ^a   Luckett, William ^a   Dubensky Jr , Thomas W ^a   Stassinopoulos, Adonis ^a  

^a CERUS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ILLUMINATION; INCUBATION TIME; NONHUMAN; PARVOVIRUS; PHOTOCHEMISTRY; POLYMERASE CHAIN REACTION; THROMBOCYTE; ULTRAVIOLET A RADIATION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTIVITY;

BLOOD PLATELETS; DNA, VIRAL; ERYTHEMA INFECTIOSUM; ERYTHROID PROGENITOR CELLS; GENOME, VIRAL; HUMANS; IMMUNOASSAY; PARVOVIRUS B19, HUMAN; PHOTOCHEMISTRY; PSORALENS; ULTRAVIOLET RAYS; VIRUS INACTIVATION;

EID: 34249102861     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01237.x     Document Type: Article

References (34)

1. van Regenmortel MH, Fauquet CM, Bishop DH, et al., editors. Virus taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses. Burlington, MA : Elsevier Academic Press 2000. p. 311 23.
2. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986 233 : 883 6.
3. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 1988 62 : 3059 63.
4. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004 53 : 459 75.
5. Cohen BJ, Beard S, Knowles WA, et al. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 1997 37 : 947 52.
6. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002 73 : 1098 100.
7. Santagostino E, Mannucci PM, Gringeri A, et al. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 1997 37 : 517 22.
8. Schneider B, Becker M, Brackmann HH, Eis-Hubinger AM. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2. Thromb Haemost 2004 92 : 838 45.
9. Schmidt I, Blumel J, Seitz H, Willkommen H, Lower J. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 2001 81 : 228 35.
10. Solheim BG, Rollag H, Svennevig JL, et al. Viral safety of solvent/detergent-treated plasma. Transfusion 2000 40 : 84 90.
11. Lefrere JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994 343 : 211 2.
12. Musiani M, Zerbini M, Gentilomi G, et al. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995 172 : 1360 3.
13. Tsujimura M, Matsushita K, Shiraki H, et al. Human parvovirus B19 infection in blood donors. Vox Sang 1995 69 : 206 12.
14. Prowse C, Ludlam CA, Yap PL. Human parvovirus B19 and blood products. Vox Sang 1997 72 : 1 10.
15. Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004 78 : 12169 78.
16. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997 37 : 423 35.
17. Lin L, Dikeman R, Molini B, et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 504.
18. Lin L, Hanson CV, Alter HJ, et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 45 : 580 90.
19. Grass JA, Hei DJ, Metchette K, et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998 91 : 2180 8.
20. Hanson D, Sawyer L, Dupuis K. ELISpot assay for the sensitive detection of infectious Parvovirus B19 [abstract]. In : 103rd Annual Meeting American Society Microbiology Washington, DC 2003.
21. van Rhenen DJ, Gulliksson H, Cazenave JP, et al. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution. Transfus Med 2004 14 : 289 95.
22. Kaufmann B, Simpson AA, Rossmann MG. The structure of human parvovirus B19. Proc Natl Acad Sci U S A 2004 101 : 11628 33.
23. Chapman MS, Rossmann MG. Structure, sequence, and function correlations among parvoviruses. Virology 1993 194 : 491 508.
24. Blumel J, Schmidt I, Willkommen H, Lower J. Inactivation of parvovirus B19 during pasteurization of human serum albumin. Transfusion 2002 42 : 1011 8.
25. Yoto Y, Kudoh T, Haseyama K, et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995 91 : 1017 8.
26. Sato H, Takakura F, Kojima E, et al. Screening of blood donors for human parvovirus B19. Lancet 1995 346 : 1237 8.
27. Caillet-Fauquet P, Di Giambattista M, Draps ML, et al. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods 2004 118 : 131 9.
28. Lazo A, Tassello J, Ohagen Å. INACTINE technology inactivates clinical isolates of parvovirus B19 in RBC concentrates as demonstrated by PCR and infectivity assays. In: The American Society of Hematology 44th Annual Meeting 2002 Philadelphia.
29. Sugawara H, Motokawa R, Abe H, et al. Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: assessment by an in vitro infectivity assay using CFU-E derived from peripheral blood CD34+ cells. Transfusion 2001 41 : 456 61.
30. Miyagawa E, Yoshida T, Takahashi H, et al. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods 1999 83 : 45 54.
31. Bonvicini F, Gallinella G, Cricca M, et al. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus. J Med Virol 2004 74 : 272 6.
32. Huang AS. Defective interfering viruses. Annu Rev Microbiol 1973 27 : 101 17.
33. Perrault J. Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 1981 93 : 151 207.
34. Van Voorhis WC, Barrett LK, Eastman RT, Alfonso R, Dupuis K. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003 47 : 475 9.